Pretreatment (before initial induction treatment) demographic and clinical characteristics of the patient population
| Characteristic . | Initial pentostatin (N = 154) n (%) . | Crossed over (N = 87) n (%) . |
|---|---|---|
| Sex | ||
| Male | 123 (80) | 70 (80) |
| Female | 31 (20) | 17 (20) |
| Age | ||
| Median (y) | 57 | 49 |
| Range | 30-82 | 29-78 |
| Performance status | ||
| 0-2 | 153 (99) | 86 (99) |
| 3 | 1 (1) | 1 (1) |
| Race | ||
| White | 152 (99) | 80 (92) |
| Other | 2 (1) | 7 (8) |
| Spleen size below costal margin | ||
| 0 | 42 (30) | 24 (30) |
| 1-4 cm | 38 (28) | 15 (19) |
| 5-9 cm | 30 (22) | 16 (20) |
| 10+ cm | 28 (20) | 24 (30) |
| Hematologic parameters | ||
| Hemoglobin (g/dL) | ||
| Median | 10.3 | 10.6 |
| Range | 5.7-15.6 | 4.0-15.4 |
| Platelets (1000/μL) | ||
| Median | 71 | 66 |
| Range | 18-378 | 7-200 |
| Granulocytes (1000/μL) | ||
| Median | 0.6 | 0.5 |
| Range | 0-11.2 | 0-9.0 |
| Characteristic . | Initial pentostatin (N = 154) n (%) . | Crossed over (N = 87) n (%) . |
|---|---|---|
| Sex | ||
| Male | 123 (80) | 70 (80) |
| Female | 31 (20) | 17 (20) |
| Age | ||
| Median (y) | 57 | 49 |
| Range | 30-82 | 29-78 |
| Performance status | ||
| 0-2 | 153 (99) | 86 (99) |
| 3 | 1 (1) | 1 (1) |
| Race | ||
| White | 152 (99) | 80 (92) |
| Other | 2 (1) | 7 (8) |
| Spleen size below costal margin | ||
| 0 | 42 (30) | 24 (30) |
| 1-4 cm | 38 (28) | 15 (19) |
| 5-9 cm | 30 (22) | 16 (20) |
| 10+ cm | 28 (20) | 24 (30) |
| Hematologic parameters | ||
| Hemoglobin (g/dL) | ||
| Median | 10.3 | 10.6 |
| Range | 5.7-15.6 | 4.0-15.4 |
| Platelets (1000/μL) | ||
| Median | 71 | 66 |
| Range | 18-378 | 7-200 |
| Granulocytes (1000/μL) | ||
| Median | 0.6 | 0.5 |
| Range | 0-11.2 | 0-9.0 |